Use of basiliximab as a cyclosporin-sparing agent in palmoplantar pustular psoriasis with myalgia as an adverse effect

被引:9
作者
Bell, HK [1 ]
Parslew, RAG [1 ]
机构
[1] Royal Liverpool Univ Hosp, Dept Dermatol, Liverpool L7 8XP, Merseyside, England
关键词
D O I
10.1046/j.1365-2133.2002.48452.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:606 / 607
页数:2
相关论文
共 3 条
[1]   Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients [J].
Nashan, B ;
Moore, R ;
Amlot, P ;
Schmidt, AG ;
Abeywickrama, K ;
Soulillou, JP .
LANCET, 1997, 350 (9086) :1193-1198
[2]   Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody [J].
Owen, CM ;
Harrison, PV .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (03) :195-197
[3]   Successful treatment of severe generalized pustular psoriasis with basiliximab (interleukin-2 receptor blocker) [J].
Salim, A ;
Emerson, RM ;
Dalziel, KL .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (05) :1121-1122